Nautilus Biotechnology
IPOUnlocking the proteome to fuel a new era of scientific discovery
Public · Seattle, United States · Founded 2016 · $90.7M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- nautilus.bio
- Total Funding
- $90.7M
- Last Round
- $14.7M Corporate RoundJul 2021
- Rounds
- 4
- Type
- Public
About
Accurate single-molecule quantification of proteins and proteoforms
Summary
Nautilus Biotechnology is an Artificial Intelligence company based in Seattle, United States, founded in 2016. It has raised $90.7M in total across 4 rounds, most recently a $14.7M Corporate Round round in Jul 2021. Investors include Arya Sciences Acquisition Corp III, Vulcan Capital and Bezos Expeditions.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2021
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
Saronic provides naval and maritime forces with intelligent Autonomous Surface Vessels at scale, ...
Global contract research organization providing comprehensive drug development and laboratory ser...